Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants

This publication has 10 references indexed in Scilit:

• Meningococcal Serogroup A Avidity Indices as a Surrogate Marker of Priming for the Induction of Immunologic Memory after Vaccination with a Meningococcal A/C Conjugate Vaccine in Infants in the United Kingdom
  The Journal of Infectious Diseases, 2001
• Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
  The Lancet, 2001
• Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK Toddlers
  The Journal of Infectious Diseases, 2001
• Production of low-avidity antibody by infants after infection with serogroup B meningococci
  The Lancet, 2000
• Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults
  Vaccine, 1999
• Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins
  Vaccine, 1999
• Avidity of IgG forStreptococcus pneumoniaeType 6B and 23F Polysaccharides in Infants Primed with Pneumococcal Conjugates and Boosted with Polysaccharide or Conjugate Vaccines
  The Journal of Infectious Diseases, 1998
• Antibody Avidity as a Surrogate Marker of Successful Priming byHaemophilus influenzaeType b Conjugate Vaccines following Infant Immunization
  The Journal of Infectious Diseases, 1998
• The immune response to a meningococcal 200 kDa surface exposed protein following carriage and disease
  Serodiagnosis and Immunotherapy in Infectious Disease, 1997
• Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine
  Vaccine, 1996